These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 6376292

  • 1. Randomised crossover trial of tripotassium dicitrato bismuthate versus high dose cimetidine for duodenal ulcers resistant to standard dose of cimetidine.
    Lam SK, Lee NW, Koo J, Hui WM, Fok KH, Ng M.
    Gut; 1984 Jul; 25(7):703-6. PubMed ID: 6376292
    [Abstract] [Full Text] [Related]

  • 2. Healing and recurrence of duodenal ulcer after treatment with tripotassium dicitrato bismuthate (TDB) tablets or cimetidine.
    Hamilton I, O'Connor HJ, Wood NC, Bradbury I, Axon AT.
    Gut; 1986 Jan; 27(1):106-10. PubMed ID: 3512382
    [Abstract] [Full Text] [Related]

  • 3. Effects of tripotassium dicitrato bismuthate (TDB) tablets or cimetidine in the treatment of duodenal ulcer.
    Hamilton I, Worsley BW, O'Connor HJ, Axon AT.
    Gut; 1983 Dec; 24(12):1148-51. PubMed ID: 6357964
    [Abstract] [Full Text] [Related]

  • 4. Comparison of cimetidine and tripotassium dicitrato bismuthate in healing and relapse of duodenal ulcers.
    Shreeve DR, Klass HJ, Jones PE.
    Digestion; 1983 Dec; 28(2):96-101. PubMed ID: 6360774
    [Abstract] [Full Text] [Related]

  • 5. Tripotassium dicitrato bismuthate (TDB) versus two different dosages of cimetidine in the treatment of resistant duodenal ulcers.
    Bianchi Porro G, Parente F, Lazzaroni M.
    Gut; 1987 Jul; 28(7):907-11. PubMed ID: 3308650
    [Abstract] [Full Text] [Related]

  • 6. Difference in relapse rates of duodenal ulcer after healing with cimetidine or tripotassium dicitrato bismuthate.
    Martin DF, Hollanders D, May SJ, Ravenscroft MM, Tweedle DE, Miller JP.
    Lancet; 1981 Jan 03; 1(8210):7-10. PubMed ID: 6109102
    [Abstract] [Full Text] [Related]

  • 7. Peptic ulcer therapy with cimetidine versus tripotassium dicitrato bismuthate in rheumatoid arthritis patients undergoing chronic NSAID treatment.
    Bianchi Porro G, Lazzaroni M, Petrillo M, Ardizzone S, Manzionna G, Caruso I, Montrone F.
    Aliment Pharmacol Ther; 1998 Apr 03; 12(4):343-7. PubMed ID: 9690723
    [Abstract] [Full Text] [Related]

  • 8. Tripotassium dicitrato-bismuthate tablets v liquid in the treatment of duodenal ulcers.
    Lane M, Lee S, Tasman-Jones C, Nicholson G.
    N Z Med J; 1985 Mar 27; 98(775):191-2. PubMed ID: 3885084
    [Abstract] [Full Text] [Related]

  • 9. [Cimetidine and tripotassium-dicitrato bismuthate (Duosol) in chronic duodenal ulcer].
    Bergoz R.
    Schweiz Med Wochenschr; 1985 Jul 20; 115(29):1024-5. PubMed ID: 4048901
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of tripotassium-dicitrato-bismuthate (TDB) and cimetidine in peptic ulcer disease, a control study of 40 gastric ulcer and 80 duodenal ulcer.
    Chearanai O, Kachintorn U, Plengvanit U.
    J Med Assoc Thai; 1987 Apr 20; 70(4):176-80. PubMed ID: 3612003
    [No Abstract] [Full Text] [Related]

  • 11. Gastric ulcer healing with tripotassium dicitrato bismuthate and subsequent relapse.
    Sutton DR.
    Gut; 1982 Jul 20; 23(7):621-4. PubMed ID: 7044913
    [Abstract] [Full Text] [Related]

  • 12. Twice daily tripotassium dicitrato bismuthate in the treatment of duodenal ulceration.
    Hollanders D.
    Postgrad Med J; 1986 Jan 20; 62(723):19-21. PubMed ID: 3540918
    [Abstract] [Full Text] [Related]

  • 13. Selective coating of gastric ulcer by tripotassium dicitrato bismuthate in the rat.
    Koo J, Ho J, Lam SK, Wong J, Ong GB.
    Gastroenterology; 1982 May 20; 82(5 Pt 1):864-70. PubMed ID: 7060908
    [Abstract] [Full Text] [Related]

  • 14. The safety and efficacy of tripotassium dicitrato bismuthate (De-Nol) maintenance therapy in patients with duodenal ulceration.
    Dunk AA, Prabhu U, Tobin A, O'Morain C, Mowat NA.
    Aliment Pharmacol Ther; 1990 Apr 20; 4(2):157-62. PubMed ID: 2104081
    [Abstract] [Full Text] [Related]

  • 15. Increased healing of gastric and duodenal ulcers in a controlled trial using tripotassium dicitrato-bismuthate.
    Lee SP, Nicholson GI.
    Med J Aust; 1977 May 28; 1(22):808-12. PubMed ID: 329077
    [Abstract] [Full Text] [Related]

  • 16. A comparative study of colloidal bismuth subcitrate and cimetidine on the healing and recurrence of duodenal ulcer.
    Vantrappen G, Schuurmans P, Rutgeerts P, Janssens J.
    Scand J Gastroenterol Suppl; 1982 May 28; 80():23-30. PubMed ID: 6761849
    [Abstract] [Full Text] [Related]

  • 17. Tri-potassium di citrato bismuthate chewing tablets and cimetidine tablets in the treatment of duodenal ulcers. A double-blind double-dummy comparative study.
    Moshal MG, Spitaels JM, Khan F.
    S Afr Med J; 1981 Sep 12; 60(11):420-3. PubMed ID: 7025264
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparison of tri-potassium di-citrato bismuthate tablets with ranitidine in healing and relapse of duodenal ulcers.
    Lee FI, Samloff IM, Hardman M.
    Lancet; 1985 Jun 08; 1(8441):1299-302. PubMed ID: 2860494
    [Abstract] [Full Text] [Related]

  • 20. Double-blind trial of cimetidine versus tri-potassium di-citrato bismuthate in chronic duodenal ulceration.
    Ward M, Pollard EJ, Cowen A.
    Med J Aust; 1981 Apr 04; 1(7):363-4. PubMed ID: 7017361
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.